Showing results (21-30 of 6,181) with videos related to
Sort By:
Pageof 619
Clinical Nephrology|July 27, 2002
Minimal change nephrotic syndrome, lymphadenopathy and hyperimmunoglobulinemia after immunization with a pneumococcal vaccineY Kikuchi, T Imakiire, T Hyodo, et al.Clinical Nephrology|July 27, 2002
Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survivalK C Abbott, I O Hypolite, L Y AgodoaClinical Nephrology|June 11, 1999
Measurement of serum leptin in patients with chronic renal failure on hemodialysisM Nishikawa, T Takagi, N Yoshikawa, et al.Clinical Nephrology|September 10, 1999
Concealed hypothyroidism in patients with myeloperoxidase antineutrophili cytoplasmic autoantibodies- (MPO-ANCA) positive renal diseaseA Tanaka, K Maeda, K Sawai, et al.Clinical Nephrology|September 10, 1999
The pattern of intracellular free amino acids in granulocytes from hemodialysis patients change to an oral protein supplement (granulocyte amino acids after protein in HD patients)P Ivarsen, J Frystyk, E B PedersenClinical Nephrology|February 8, 2000
Prognostic value of a new scoring system for hospital mortality in acute renal failureR L Lins, M Elseviers, R Daelemans, et al.Clinical Nephrology|February 8, 2000
Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapyC van Guldener, J Lambert, P M ter Wee, et al.Clinical Nephrology|February 8, 2000
Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patientsC Canavese, A Grill, E Decostanzi, et al.Clinical Nephrology|July 6, 2000
Cerebral ischemia as a causative mechanism for rapid progression of brain atrophy in chronic hemodialysis patientsT Yoshimitsu, H Hirakata, K Fujii, et al.Clinical Nephrology|July 6, 2000
The effect of vanadium-contaminated commercially available albumin solutions on renal tubular functionG Heinemann, S Braun, M Overbeck, et al.Pageof 619